chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A large rash on my left arm that was itchy; Arm tightness; Warm to the touch; Had pain on injection site; Big rash on the injection site; Swollen rash on injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (A large rash on my left arm that was itchy), LIMB DISCOMFORT (Arm tightness), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PAIN (Had pain on injection site) and VACCINATION SITE RASH (Big rash on the injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D3 for an unknown indication.    On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (A large rash on my left arm that was itchy), LIMB DISCOMFORT (Arm tightness), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PAIN (Had pain on injection site), VACCINATION SITE RASH (Big rash on the injection site) and VACCINATION SITE SWELLING (Swollen rash on injection site). On 08-Jan-2021, VACCINATION SITE PRURITUS (A large rash on my left arm that was itchy), LIMB DISCOMFORT (Arm tightness), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PAIN (Had pain on injection site), VACCINATION SITE RASH (Big rash on the injection site) and VACCINATION SITE SWELLING (Swollen rash on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient was prescribed a topical cream (unspecified). The patient received the second dose of mRNA-1273 (Moderna COVID-19 Vaccine) on 24-Jan-2021 in right arm.   This case was linked to MOD-2021-082291 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: FUP obtained included: new events after dose 1, second dose details and adverse events associated with it.; Reporter's Comments: This case concerns a female of unknown age who experienced NS events of unexpected limb discomfort and expected injection site pain, Injection site swelling, Injection site rash.  Event onset occurred on Day 2 after the first dose of mRNA-1273, followed by other events on Day 8. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association.
Marked erythema, edema, induration at the injection site. Warm compresses applied by parents. Resolved after 1 week.
jitteriness, mottled appearance of skin, tachycardia, dyspnea;
Red itchy hives on multiple areas of body to include face, arms, legs, and abdomen. Began approximately 4 hours after injection on legs: after overnight red bumps/hives appeared on other areas as above.
Pain during administration of vaccine. No tingling or radiation down arm. Pain in shoulder joint of left arm and increased since time of vaccination. Range of motion decreased. Saw ortho MD 9/30/14 - had cortisone injection into shoulder area. To be seen again in 6 weeks, sooner if no improvement.
Starting the evening after receiving the vaccine, I developed mild fatigue and a sore arm. It wasn't until about 1-2 weeks later that I developed another flare up of my Psoriasis on my elbows and the base of my hair line. I self treated with steroid cream but it has yet to go back down on its own. I have an appointment with my dermatologist on Monday for an annual exam and I will ask her then. Also, my pre-existing tinnitus has worsened in the left ear and has yet to come back down.
Hospitalization for COVID on dates 7/7/22-7/8/22. Treated with dexamethasone, prednisone, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Breakthrough case admission after 3 vaccines Moderna 2/14/21 Lot# 038K20a;  Moderna 3/14/21 Lot# 044A21A;  Moderna 11/24/21 Lot# 012H21B;
Later that evening at 7pm, felt achiness in upper legs. At 2:30 a.m. woke with sweating, fever/chills, difficulty hearing, felt chest pressure like having a heart attack, bad headache, weakness, couldn't drink water bottle. Went to the ER after that.
Initially she was fine during 15 minutes observation period. Facial redness/itching developed around 15-20 minutes after shot on 1/7/21. No rash anywhere else on body. Numbness in face. Headache. Per patient, co-nurses told her she had facial swelling.  No trouble breathing. No throat swelling. No cough.  Got famotidine and Benadryl. blood pressure was elevated (228/120). She felt better after about 2 hours.
8cmx8cm warmth, redness, induration 6cmx6cm to left deltoid cool compresses, benadryl
Patient is a 22 year old male who received an undiluted 0.3ml dose of the pediatric Pfizer BioNTech Covid-19 Bivalent. No adverse side effects or symptoms were noted at the time of administration.  (rehab facility where patient resides) was notified and no adverse effects were reported as of 12/15/22 at 12:26 pm.
Passed out and 911 was called They said  blood pressure and blood sugar were low They gave patient  a glass of orange juice and offered to take patient to the hospital, but patient refused.
TOOK TWO DOSES IN A ROW; This case (PVX2019-2196) was received form a pharmacist on 28-Aug-2019. It described an adult male consumer (age in between 18 to 64 years), who "took two doses in a row" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took the first there doses as directed. However, the third and the fourth dose of Vivotif were taken in a row.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
3/13/2021 migraine headache the following day, never had a migraine before, woke up at 5:00 A.M. the following morning with eyes feeling very heavy, headache and lightheaded, sunlight bothered me. Took Advil and stayed in a darkened room. Felt fine 3/14/21 when I woke up.
4/11/13 MOP report R. leg Red warm, swollen, approx 2 inches in diameter. Child tearful. 100 mg ibuprofen given 8pm & 7am. Provide Rx KEFLEX 8:30am 4/12/13.
Cellulitis, increased BP 2 days after PNEUMOVAX 23 given. Pt prescribed KEFLEX 500 QID x 10 days and OTC diphenhydramine from PCP.
Pt. presented to ER at 8pm 2/5/04 after having received 6 immunizations earlier same day.  Child was having febrile seizures.  CBC done @ hospital with other tests done.  No medication given/prescribed. Child appeared to be OK  at PE 2/6/04. Medical record received on 3/23/04 states body ridged, arms shaking, lethargic, fussy, viral illness, emesis and eye infected.
pt recv vax 16JUL92 & approx 4wk later began to exp progressive numbness in both hands, motor weakness, reflex loss, widespread delays on nerve conduction;neuro dx chronic progressive demyelinating polyneuropathy;
Nausea for 24 hours with dry heaves; headache; shakes; increase in blood pressure and heartrate
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 18-MAY-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion three times. The total cumulative excursion time of the first time was 212 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree. The total cumulative excursion time of the third time was 828 hours with the lowest recorded temperature of 29 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Diarrhea and shortness of breath which was reported approximately 17 days after the injection. She stated PREVNAR caused her pneumonia (PREVNAR is a killed vaccine) and that the eggs in the product also caused the reaction (PREVNAR does not contain eggs).
A nurse reported that a 28-year-old female received Flu Shield on 10/28/99 and 10/29/99. She developed cellulitis. She was treated with Keflex twice daily. The pt recovered within 5 days. On 12/10/99, the pt developed numbness, tingling, and weakness in most of her affected arm.
Mother reports the day after immunization given, injection site became red, swollen, hot.  Swelling increased on second day,patient reported site "itchy" on second day, and itching is still being reported by patient.  Mother states patient was seen by family MD, MD verified was a reaction vs. infection.  Site observed on 05/19/2004 by this RN and faint redness noted, skin normal temperature.
A non-serious spontaneous report of "7 patients were inadvertently administered expired H1N1" was received from a health professional concerning a ten-year-old male out of seven patient. Neither relevant medical history nor concomitant medications have been reported for this patient. The vaccine expired on 15-Jan-2010. On 01-Feb-2010, the patient received the expired H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments were not applicable and the event was considered resolved.
very little discomfort in my arm; steady pain in the back of my head; rash on my back, it looked similar to chicken pox; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very little discomfort in my arm), HEADACHE (steady pain in the back of my head) and RASH (rash on my back, it looked similar to chicken pox) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Bronchiectasis from November 2020 to 30-Mar-2021. Concomitant products included ATORVASTATIN for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced RASH (rash on my back, it looked similar to chicken pox). On an unknown date, the patient experienced PAIN IN EXTREMITY (very little discomfort in my arm) and HEADACHE (steady pain in the back of my head). On 02-Mar-2021, RASH (rash on my back, it looked similar to chicken pox) had resolved. At the time of the report, PAIN IN EXTREMITY (very little discomfort in my arm) and HEADACHE (steady pain in the back of my head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were given.   This case was linked to MOD-2021-052089 (Patient Link).
Child has hard, red, indurated patch on left leg (8 cm X 6cm) has been fussy, febrile since Wed.
Pt states "I feel like I need to scratch REALLY bad." Redness noted around the bandaid by staff. PO benadryl 25 mg administered at 0855. Pt denies any difficulty breathing or swallowing, denies any SOB. @0933 pt states " i am no longer itching and the redness is much better"   observation by staff confirms that redness is decreased
Patient vomited immediately after vaccination. She sat for approximately 7 minutes with an ice pack before asking to walk somewhere to lay down. About 100 feet in to the walk, she fainted. She was being supported on both sides by pharmacist and het boyfriend, so she went to the ground gently.
Dissection of right carotid artery, migraines, episodic Anisocoria.  Eliquis 5 mg twice daily Aspirin 325 mg once daily
fatigue; chills / extreme shivering; fever; This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included alpha-gal allergy.   On 19th August 2020, the patient received the 1st dose of Shingrix. On 19th August 2020, less than a day after receiving Shingrix, the patient experienced fatigue, chills and fever. On an unknown date, the outcome of the fatigue, chills and fever were unknown.   It was unknown if the reporter considered the fatigue, chills and fever to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in her right arm and experience fever, chills, extreme shivering, and fatigue. The reporter consented to follow up.  This case linked with US2020167483 and US2020AMR167887, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR167887:same reporter US-GLAXOSMITHKLINE-US2020167483:same reporter
He reported feeling dizzy after walking to the observation area. He denies any other symptoms. BP 88/60mmHg, HR 60 bpm, SPO2 99%.  After time in the recliner chair he stated he was no longer feeling symptomatic.  BP 110/64mmHg, HR 71bpm, SPO2 99%
I got the final vaccine on Sept 30th, on October 2nd, I started to feel pain in my hip, I went to the local ER I started to feel pain still in my hip. They Admitted me on October 5th, and they discovered a blood clot. I was in the hospital for a week. They did a procedure where they cleaned out the stent. They put a cather in there, and cleaned it out. I was there for 5-6 days. I came home, like the next day or so, I started to get the pain in my hip again. I thought it was coming from a repaired hip, but after the xrays, the hip looked fine. I now have more upcoming xrays to my spine, my hip and my shoulder (pain in shoulder too) this coming week, the 23rd. I also have physical therapy.
first / vaccine two years ago; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient asked could get 2nd shot or did have to restart again.
Patient received first dose Moderna Vaccine at Pharmacy on 5/16/21.  She presented for her second dose on 7/31/21.  This is beyond the recommended period between doses and so it is being reported as an adverse event.
This spontaneous report as received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The reporter stated that since 28-JUL-2014 an unspecified number of patients have been administered GARDASIL (dose, units, frequency, lot number were not reported) that was improperly stored. This excursion was supported. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Numbness/tingly/ticklish  along the left side of my body (I.e. foot, ankle, calf, hip, pinky, wrist, and face).
tiredness, muscle discomfort, headache, cold feet, fever - 101.2, slight nausea  started the next day and lasted for the whole day - better the next day
Felt tired; Arm discomfort; Limited range of motion of arm; This case was reported by a pharmacist via call center representative and described the occurrence of arm discomfort in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number JC55P, expiry date 15th November 2021) for prophylaxis.   On 15th August 2019, the patient received the 2nd dose of Shingrix. On 16th August 2019, 1 days after receiving Shingrix, the patient experienced arm discomfort and joint range of motion decreased. On an unknown date, the patient experienced tiredness. On an unknown date, the outcome of the arm discomfort and joint range of motion decreased were not recovered/not resolved and the outcome of the tiredness was unknown.   It was unknown if the reporter considered the arm discomfort, joint range of motion decreased and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and a day after began experiencing arm discomfort and limited range of motion of her arm. It had slightly improved but had not resolved. She also felt tired but feels tired normally. The reporter consented to follow up. The registered pharmacist agreed to follow up. This case is 2 of the 2 linked cases, reported by the same reporter.
extremely tired; Slow speech; walking like a drunk; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 70 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in left arm, administration date 04Mar2021 (Lot number: EN6202) at the age of 70 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FATIGUE (non-serious) with onset 08Mar2021, outcome "recovering", described as "extremely tired"; SLOW SPEECH (non-serious) with onset 08Mar2021, outcome "recovering", described as "Slow speech"; GAIT DISTURBANCE (non-serious) with onset 08Mar2021, outcome "recovering", described as "walking like a drunk".  No follow-up attempts are possible. No further information is expected.
pt recv vax & post vax exp erythematous eruptions;ER or MD visit was required;
pt had been taking Bactrim for skin problem 1 1/2 wk a/MMR given; 22JUN pt noticed general rash & nausea; 23JUN rash inc along w//nausea, joint pain, cold & hot episodes & red eyes; 23JUN discontinued Bactrim;
Growing rash on both thighs, rash is bumpy, red, raised. Patient fever, fussy, some wheezing in upper lungs (breathing normally).
Fever Documented from 101-99 Daily since taking vaccine. Record blood pressure reading: 158/110 - tonight (It's been consistently 145/93) which is pretty high for me. Daily headaches - I wake up with a flu like headache everyday Feeling Fatigue - I've been feeling fatigue daily staying in bed resting, and I notice when I get up and move around my blood pressure spikes and my fever elevates. Nausea/Dizziness - Feeling a little sick to my stomach, similar to motion sickness. Overall  I just haven't been feeling like my self since taking it.
Warm to the touch at the site of injection; Itchy at the site of injection; A rash at the site of injection; Red at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided. No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up received provided no new information.
injection site being sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Jan2021 04:21 (Lot number: EC9263) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Prostate relax" (unspecified if ongoing); "Blood Pressure" (unspecified if ongoing). Concomitant medication(s) included: FENOFIBRATE (ongoing); TAMSULOSIN taken for prostate tenderness (ongoing); ACEBUTOLOL taken for blood pressure abnormal (ongoing); NIFEDIPINE taken for blood pressure abnormal (ongoing). The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "injection site being sore".  Additional Information: It was stated that there were no previous vaccines. The concomitant medications had been started  since long time. There was no relevant tests.  No follow-up attempts are possible. No further information is expected.
Information has been received from a case worker concerning a 3 month old female pt who in approximately 10/00 was vaccinated with a dose of varicella virus vaccine live. Within two days in approximately 10/00, the pt began developing a severe eczema with open sores that occasionally seep. The rash has been treated several times and continued to come back. FOLLOW- UP  information has been received from a nurse in the physician's office who reported that the pt did not receive varicella virus vaccine live in this physician's office at 3 months of age or at any other time from this physician's office staff. The nurse stated that the child was up to date on the normal childhood vaccines until the child left the office at 9 months of age. The nurse reported that the child did have eczema and was seen in the office for the eczema. The nurse stated that the pt's mother insists her child received varicella virus vaccine live at 3 months of age. No further information is available.